Fogler’s April 27 Picks Target TMX, Citi and Smith & Nephew as Compounding Winners

Why It Matters

Fogler’s recommendations underscore a broader shift among long‑term investors toward businesses that can lock in recurring revenue and reinvest earnings into growth. By spotlighting TMX’s monopoly‑like position in Canadian market infrastructure, Citi’s strategic refocus, and Smith & Nephew’s demographic tailwinds, the picks illustrate how compounding can be engineered through operational moat and sector resilience. For retail and institutional investors alike, the emphasis on multi‑year holding periods challenges the prevailing short‑term trading mindset and reinforces the value of patient capital in a market that historically trends upward. Moreover, the picks could influence fund flows. If Kingwest’s Avenue Fund continues to outperform, other managers may allocate more capital to similar high‑moat, restructuring‑driven stocks, potentially lifting valuations and tightening spreads in these niches. The ripple effect may also prompt analysts to re‑evaluate earnings forecasts for the highlighted firms, especially as TMX’s recent acquisitions could reshape competitive dynamics in global exchange services.

Key Takeaways

• Richard Fogler, CIO of Kingwest & Company, names TMX Group, Citigroup and Smith & Nephew as top picks for April 27, 2026.
• TMX Group recently acquired CBOE Canada and CBOE Australia, expanding its market‑share in mining listings to nearly 50 %.
• Fogler has held TMX since its 2003 IPO at US$3.50 per share, citing a 22‑year track record of regulated monopoly growth.
• Kingwest’s Avenue Fund turned a US$100,000 index investment into US$3 million over 30 years, illustrating the power of compounding.
• Citigroup’s CEO Jane Fraser is shrinking the bank’s consumer footprint to focus on corporate, securities and wealth‑management services.

Pulse Analysis

Fogler’s three‑stock thesis reflects a classic ‘moat‑plus‑turnaround’ playbook that has resonated with value investors for decades. TMX’s integrated exchange platform offers a rare blend of network effects and regulatory barriers, making it a de‑facto monopoly in Canadian capital markets. The recent CBOE acquisitions not only eliminate a direct competitor but also deepen TMX’s exposure to resource‑heavy economies, a sector that historically outperforms during commodity up‑cycles. As long as the firm can monetize its data and clearing services, earnings should exhibit low volatility and high margins, traits that reward patient investors.

Citigroup’s inclusion signals a belief that large banks can reinvent themselves through disciplined divestitures and a focus on high‑margin corporate banking. Jane Fraser’s strategy mirrors the post‑financial‑crisis trend of simplifying balance sheets to reduce risk‑weighted assets, which could improve return on equity and capital efficiency. If Citi can sustain cost reductions while expanding its global corporate franchise, the stock may re‑price to reflect a higher earnings multiple, narrowing the discount to peers.

Smith & Nephew adds a healthcare dimension, offering exposure to an aging global population and the shift toward minimally invasive procedures. The company’s pipeline of orthopaedic and wound‑care products aligns with long‑term demand drivers that are less correlated with macro‑economic swings. Together, these picks form a diversified trio that balances defensive infrastructure, financial sector transformation, and secular health trends—an archetype of compounding assets that can thrive across market cycles. Investors who adopt Fogler’s five‑year horizon may capture the 8‑10 % annual market drift while mitigating short‑term turbulence.